C.M. Kuiper

1.6k total citations
21 papers, 1.4k citations indexed

About

C.M. Kuiper is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, C.M. Kuiper has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 9 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in C.M. Kuiper's work include Drug Transport and Resistance Mechanisms (12 papers), Genetic factors in colorectal cancer (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). C.M. Kuiper is often cited by papers focused on Drug Transport and Resistance Mechanisms (12 papers), Genetic factors in colorectal cancer (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). C.M. Kuiper collaborates with scholars based in Netherlands, Switzerland and Norway. C.M. Kuiper's co-authors include Herbert M. Pinedo, J. Lankelma, HJ Broxterman, Godefridus J. Peters, H. M. Pinedo, C.K. van Kalken, N Feller, C. H. M. Versantvoort, H J Broxterman and Andries M. Bergman and has published in prestigious journals such as The Lancet, British Journal of Cancer and Annals of Oncology.

In The Last Decade

C.M. Kuiper

21 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C.M. Kuiper Netherlands	15	1.1k	665	278	214	147	21	1.4k
G L Scheffer Netherlands	13	1.3k 1.2×	780 1.2×	308 1.1×	274 1.3×	132 0.9×	14	1.7k
Eugene Mechetner United States	19	1.0k 1.0×	706 1.1×	227 0.8×	145 0.7×	144 1.0×	39	1.8k
C.K. van Kalken Netherlands	13	808 0.8×	475 0.7×	241 0.9×	238 1.1×	81 0.6×	17	1.1k
Lewis M. Slater United States	21	925 0.9×	647 1.0×	192 0.7×	203 0.9×	120 0.8×	68	1.7k
Ken Shiozawa Japan	16	861 0.8×	687 1.0×	196 0.7×	174 0.8×	107 0.7×	24	1.3k
Peter R. Twentyman United Kingdom	22	884 0.8×	787 1.2×	168 0.6×	119 0.6×	108 0.7×	48	1.5k
E Schneider United States	17	1.1k 1.0×	1.0k 1.5×	253 0.9×	170 0.8×	58 0.4×	21	1.8k
Elizabeth Hopper-Borge United States	18	954 0.9×	638 1.0×	243 0.9×	168 0.8×	103 0.7×	20	1.5k
D D Ross United States	13	1.1k 1.1×	698 1.0×	357 1.3×	154 0.7×	47 0.3×	15	1.4k
S. E. Salmon United States	19	949 0.9×	625 0.9×	121 0.4×	180 0.8×	183 1.2×	43	1.8k

Countries citing papers authored by C.M. Kuiper

Since Specialization

Citations

This map shows the geographic impact of C.M. Kuiper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.M. Kuiper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.M. Kuiper more than expected).

Fields of papers citing papers by C.M. Kuiper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.M. Kuiper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.M. Kuiper. The network helps show where C.M. Kuiper may publish in the future.

Co-authorship network of co-authors of C.M. Kuiper

This figure shows the co-authorship network connecting the top 25 collaborators of C.M. Kuiper. A scholar is included among the top collaborators of C.M. Kuiper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.M. Kuiper. C.M. Kuiper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bergman, Andries M., C.M. Kuiper, Finn Myhren, et al.. (2004). Antiproliferative Activity and Mechanism of Action of Fatty Acid Derivatives of Arabinosylcytosine (ara‐C) in Leukemia and Solid Tumor Cell Lines. Nucleosides Nucleotides & Nucleic Acids. 23(8-9). 1523–1526. 22 indexed citations

Bergman, Andries M., C.M. Kuiper, Daphne Voorn, et al.. (2003). Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines. Biochemical Pharmacology. 67(3). 503–511. 73 indexed citations

Backus, Harold H.J., Herbert M. Pinedo, D. Wouters, et al.. (2001). Differences in the Induction of DNA Damage, Cell Cycle Arrest, and Cell Death by 5-Fluorouracil and Antifolates. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 12(5). 231–239. 40 indexed citations

Backus, Harold H.J., Herbert M. Pinedo, D. Wouters, et al.. (2000). Differences in the induction of DNA damage, cell cycle arrest, and cell death by 5-fluorouracil and antifolates. Oncology Reports. 12(5). 1 indexed citations

Peters, Godefridus J., Baukelien van Triest, Harold H.J. Backus, et al.. (2000). Molecular downstream events and induction of thymidylate synthase in mutant and wild-type p53 colon cancer cell lines after treatment with 5-fluorouracil and the thymidylate synthase inhibitor raltitrexed. European Journal of Cancer. 36(7). 916–924. 77 indexed citations

Moorsel, C.J.A. van, Herbert M. Pinedo, G. Veerman, et al.. (1999). Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines. British Journal of Cancer. 80(7). 981–990. 176 indexed citations

Peters, Godefridus J., Daphne Voorn, C.M. Kuiper, et al.. (1999). Cell Specific Cytotoxicity and Structure-Activity Relationship of Lipophilic 1-B-D-Arabinofuranosylcytosine (Ara-C) Derivatives. Nucleosides and Nucleotides. 18(4-5). 877–878. 8 indexed citations

Boven, Epie, HM Pinedo, P Scheffer, et al.. (1998). Characterization of human soft-tissue sarcoma xenografts for use in secondary drug screening. British Journal of Cancer. 78(12). 1586–1593. 8 indexed citations

Linn, S. C., Giuseppe Giaccone, P. J. van Diest, et al.. (1995). Prognostic relevance of P-glycoprotein expression in breast cancer. Annals of Oncology. 6(7). 679–685. 73 indexed citations

10.

Feller, N, C.M. Kuiper, J. Lankelma, et al.. (1995). Functional detection of MDR1/P170 and MRP/P190-mediated multidrug resistance in tumour cells by flow cytometry. British Journal of Cancer. 72(3). 543–549. 139 indexed citations

11.

Versantvoort, C. H. M., Sebo Withoff, HJ Broxterman, et al.. (1995). Resistance‐associated factors in human small‐cell lung‐carcinoma GLC₄ sub‐lines with increasing adriamycin resistance. International Journal of Cancer. 61(3). 375–380. 56 indexed citations

12.

Schuurhuis, G.J., H J Broxterman, GJ Ossenkoppele, et al.. (1995). Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia.. PubMed. 1(1). 81–93. 72 indexed citations

13.

Broxterman, Henricus J., N Feller, C.M. Kuiper, et al.. (1995). Correlation between functional and molecular analysis of mdr1 P‐glycoprotein in human solid‐tumor xenografts. International Journal of Cancer. 61(6). 880–886. 9 indexed citations

14.

Linn, SC, Giuseppe Giaccone, C.K. van Kalken, et al.. (1994). Complete remission of colorectal cancer: a pitfall in a multidrug resistance reversal trial. The Lancet. 343. 1648–1649. 2 indexed citations

15.

Pinedo, Herbert M., C.M. Kuiper, Carsten R. Lincke, et al.. (1994). Biochemical modulation of ‘classical’ multidrug resistance by BIBW22BS, a potent derivative of dipyridamole. Annals of Oncology. 5(8). 733–739. 10 indexed citations

16.

Versantvoort, C. H. M., GJ Schuurhuis, H. M. Pinedo, et al.. (1993). Genistein modulates the decreased drug accumulation in non-P-glycoprotein mediated multidrug resistant tumour cells. British Journal of Cancer. 68(5). 939–946. 128 indexed citations

17.

Kalken, C.K. van, Giuseppe Giaccone, Paul van der Valk, et al.. (1992). Multidrug resistance gene (P-glycoprotein) expression in the human fetus.. PubMed. 141(5). 1063–72. 106 indexed citations

18.

Versantvoort, C. H. M., H J Broxterman, Herbert M. Pinedo, et al.. (1992). Energy-dependent processes involved in reduced drug accumulation in multidrug-resistant human lung cancer cell lines without P-glycoprotein expression. Lung Cancer. 8(3-4). 235–235. 90 indexed citations

19.

Kalken, C.K. van, P. van der Valk, Rob Pieters, et al.. (1991). Differentiation dependent expression of P-glycoprotein in the normal and neoplastic human kidney. Annals of Oncology. 2(1). 55–62. 34 indexed citations

20.

Schuurhuis, GJ, HJ Broxterman, H. M. Pinedo, et al.. (1991). Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. British Journal of Cancer. 64(5). 857–861. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact